Marshall Wace, LLP Personalis, Inc. Transaction History
Marshall Wace, LLP
- $72.2 Billion
- Q2 2024
A detailed history of Marshall Wace, LLP transactions in Personalis, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 109,852 shares of PSNL stock, worth $591,003. This represents 0.0% of its overall portfolio holdings.
Number of Shares
109,852
Previous 210,902
47.91%
Holding current value
$591,003
Previous $314,000
59.24%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding PSNL
# of Institutions
74Shares Held
22.3MCall Options Held
27.5KPut Options Held
0-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.36MShares$34.2 Million0.07% of portfolio
-
Black Rock Inc. New York, NY3.29MShares$17.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.9MShares$10.2 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.06MShares$5.69 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.03MShares$5.54 Million0.0% of portfolio
About Personalis, Inc.
- Ticker PSNL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 45,918,400
- Market Cap $247M
- Description
- Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...